←Back to Expert Scholars
Translational Medicine / 转化医学TET2, Myeloid Malignancies
Ross Levine
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Deputy Physician-in-Chief
130
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ross Levine is a leading physician-scientist in myeloid malignancies who elucidated TET2 and JAK2 roles in clonal hematopoiesis and MPN. His translational program bridges clonal hematopoiesis, MDS, and AML to understand leukemic stem cell evolution.
Share:
🧪Research Fields 研究领域
TET2 mutations
JAK2 MPN
IDH2 leukemia
clonal evolution
preleukemic HSC
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ross Levine 的研究动态
Follow Ross Levine's research updates
留下邮箱，当我们发布与 Ross Levine（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment